Anika Therapeutics Inc. (ANIK)
NASDAQ: ANIK
· Real-Time Price · USD
8.77
0.13 (1.50%)
At close: Aug 15, 2025, 3:08 PM
Anika Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -4.87M | -21.86M | -29.92M | -88K | -4.51M | -63M | -6.58M | -2.74M | -10.35M | -4.91M | -4.17M | -2.84M | -2.93M | -5.79M | 558K | 6.53M | 2.84M |
Depreciation & Amortization | 1.59M | 1.81M | 1.65M | 2.06M | 2.6M | 3.59M | 3.54M | 3.55M | 3.55M | 3.67M | 3.5M | 3.71M | 3.62M | 3.73M | 3.58M | 3.5M | 3.51M |
Stock-Based Compensation | 2.86M | 2.25M | 3.39M | 3.89M | 3.59M | 3.81M | 3.56M | 4.15M | 3.72M | 3.81M | 3.88M | 4.08M | 2.54M | 3.17M | 2.86M | 2.8M | 2.26M |
Other Working Capital | -3.87M | -1.36M | 13.38M | -1.7M | -4.11M | 324K | 3.92M | -4.02M | 361K | -311K | 1.25M | 2.9M | -5.13M | -1.3M | -1.06M | 4.37M | -2.79M |
Other Non-Cash Items | 539K | 21.51M | 17.85M | 15.44M | 11.04M | 63.69M | 3.73M | 1.25M | 1.2M | 2.15M | 3.75M | 653K | 994K | 5.25M | -341K | -8.81M | -750K |
Deferred Income Tax | 18K | 234K | -184K | 17K | 193K | -1.84M | -1.21M | -904K | -2.37M | -1.78M | -1.47M | -1.75M | -273K | -2.78M | -178K | 2.36M | -1.16M |
Change in Working Capital | -269K | -2.36M | 12.22M | -8.04M | -4.18M | -2.61M | 3.44M | -13.59M | 642K | -2.47M | -2.77M | -765K | -5.82M | 904K | -4.42M | -2.08M | -9.12M |
Operating Cash Flow | -130K | 1.58M | 5.02M | -1.07M | -126K | 3.64M | 6.49M | -8.29M | -3.62M | 481K | 2.71M | 3.09M | -1.87M | 4.47M | 2.06M | 4.29M | -2.43M |
Capital Expenditures | -2.82M | -1.31M | -1.22M | -3.4M | -1.81M | -1.84M | -741K | -1.46M | -1.39M | -2.53M | -1.69M | -1.94M | -1.33M | -1.13M | -1.28M | -2.31M | -417K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -113K | -11K | -2K | -350K |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.5M |
Other Investing Acitivies | 4.5M | n/a | -600K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.5M |
Investing Cash Flow | 1.67M | -1.31M | -1.82M | -3.4M | -1.81M | -1.84M | -741K | -1.46M | -1.39M | -2.53M | -1.69M | -1.94M | -1.33M | -1.24M | -1.29M | -2.32M | 1.73M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -231K | -22K | -31K | 9K | -63K | -28K | -119K |
Common Stock Repurchased | -3.97M | -5.58M | -3.97M | -1.37M | -2.3M | 7K | -110K | -5M | n/a | 1K | -65K | -24K | -846K | -63K | -70K | -21K | -332K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -1.47M | n/a | -22K | -205K | -2.27M | 342K | -110K | -429K | -1.61M | 667K | -4.38M | -24K | -831K | 51K | -6.92M | 622K | -332K |
Financial Cash Flow | -5.44M | -5.35M | -3.99M | -1.11M | -2.27M | 342K | -110K | -4.94M | -1.61M | 667K | -4.61M | -46K | -862K | 60K | -6.98M | 594K | -451K |
Net Cash Flow | -3.79M | -5.21M | -454K | -5.81M | -4.24M | 2.22M | 5.58M | -14.67M | -6.59M | -1.45M | -3.62M | 1.07M | -4.06M | 3.41M | -6.21M | 2.58M | -1.22M |
Free Cash Flow | -2.95M | 275K | 3.8M | -4.47M | -1.93M | 1.8M | 5.74M | -9.75M | -5.01M | -2.05M | 1.02M | 1.15M | -3.19M | 3.35M | 778K | 1.98M | -2.85M |